Elotuzumab in combination with dose reduced IMiDs and dexamethasone for AL amyloidosis patients with relapsed/refractory plasma cell dyscrasia and advanced organ involvement

Saved in:
Bibliographic Details
Main Authors: Dittrich, Tobias (Author) , Hansen, Timon (Author) , Kimmich, Christoph (Author) , Veelken, Kaya (Author) , Jauch, Anna Sophia (Author) , Raab, Marc-Steffen (Author) , Müller-Tidow, Carsten (Author) , Hegenbart, Ute (Author) , Schönland, Stefan (Author)
Format: Article (Journal)
Language:English
Published: June 2025
In: American journal of hematology
Year: 2025, Volume: 100, Issue: 6, Pages: 1098-1101
ISSN:1096-8652
DOI:10.1002/ajh.27684
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ajh.27684
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.27684
Get full text
Author Notes:Tobias Dittrich, Timon Hansen, Christoph R. Kimmich, Kaya Veelken, Anna Jauch, Marc S. Raab, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland
Description
Item Description:Online veröffentlicht: 25. April 2025
Gesehen am 21.10.2025
Physical Description:Online Resource
ISSN:1096-8652
DOI:10.1002/ajh.27684